Applied Therapeutics Inc.
(APLT)
undefined
undefined%
At close: undefined
0.91
4.05%
Pre-market Jan 07, 2025, 05:03 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -2.36 | -0.35 | -2.19 | -5.2 | -7.71 | -5.21 | -20.12 |
| PS Ratio | 28.24 | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | -16.46 | 7.08 | 3.66 | 5.90 | 10.73 | 5.45 | -21.75 |
| P/FCF Ratio | -5.12 | -0.37 | -2.53 | -6.18 | -9.64 | -7.7 | -26.96 |
| P/OCF Ratio | -5.12 | -0.37 | -2.53 | -6.18 | -9.64 | -7.7 | -26.96 |
| OCF/S Ratio | -5.52 | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -0.02 | 0.22 | 0.02 | 0.02 | 0.06 | n/a | n/a |
| Quick Ratio | 0.76 | 1.12 | 3.36 | 4.86 | 3.27 | 4.57 | 3.31 |
| Current Ratio | 0.76 | 1.12 | 3.34 | 4.83 | 3.27 | 4.57 | 3.31 |
| Asset Turnover | 0.18 | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | -190.3 | -168.99 | -490.13 | n/a | n/a |
| Return on Equity (ROE) | 6.98 | -20.12 | -1.67 | -1.14 | -1.39 | -1.04 | 1.08 |
| Return on Assets (ROA) | -2.18 | -2.13 | -1.16 | -0.89 | -0.94 | -0.82 | -1.3 |
| Return on Capital (ROIC) | 3.95 | -16.79 | -1.67 | -1.13 | -1.33 | -0.85 | -1.87 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 96.47% | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -1.20K% | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -1.20K% | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -645.8% | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -552.12% | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -645.79% | n/a | n/a | n/a | n/a | n/a | n/a |